AI in Biopharma Manufacturing: Are We There Yet? podcast

Grading: How Much Does This Model Matter?

0:00
30:49
Rewind 15 seconds
Fast Forward 15 seconds
Seven documents grade models seven ways, and they grade different things. Sam and Sarah start with the 2011 ICH Points to Consider, which graded models low, medium and high by their role in assuring quality and made 'sole indicator' the line, then set beside it FDA's and M15's model risk, Annex 22's critical-or-not test and model-type gate, the AI Act's product tiers, and BioPhorum's redefinition of model influence as maturity. Four tiers emerge for the season. All four recurring systems are placed and moved, and the agentic assistant's tier turns out to be an argument about criticality that has to be won first. Researched, scripted and voiced by AI systems under Jack Prior's direction. Sam and Sarah are AI characters; nothing in the episode is Jack speaking, and none of it is a statement of his views or his employer's. Generative AI can be confidently wrong — check the sources. Corrections: [email protected]. Transcript: https://jackprior.ai/podcast/transcript/03-grading.html Documents discussed: Q8/Q9/Q10 Points to Consider — ICH-endorsed implementation guide: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-ich-quality-implementation-working-group-points-consider-ich-q8q9q10-guidelines_en.pdf AI CMC Model Impact Crosswalk: https://jackprior.ai/ai-cmc-landscape/ Q9(R1): https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2023_0126_0.pdf Annex 22 — Artificial Intelligence: https://picscheme.org/docview/9715 Regulation (EU) 2024/1689 — AI Act: https://eur-lex.europa.eu/eli/reg/2024/1689/oj/eng BioPhorum — AI risk guidance for the pharmaceutical industry: Harmonizing frameworks for practical implementation: https://www.biophorum.com/download/artificial-intelligence-risk-guidance-for-the-pharmaceutical-industry-harmonizing-frameworks-for-practical-implementation/ Fact check: 69 factual claims in this episode were checked against the source documents by an independent AI pass: 62 are supported by the primary text, 6 are confirmed by official web sources, 1 rest on secondary sources or are hedged as such (listed in the report), 0 open. Full report: https://jackprior.ai/podcast/factcheck/03-grading.html

More episodes from "AI in Biopharma Manufacturing: Are We There Yet?"